Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synaptrix Labs
New York, New York, United Statessynaptrix-labs.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Synaptrix Labs has developed Neuralis™, a non-invasive, EEG-based brain-computer interface currently in clinical trials to enable wheelchair control and diagnostic applications. The company also offers NOVABLOC™, a wearable neurostimulation device undergoing randomized controlled trials for long-lasting, opioid-free postoperative pain relief. Early pilot studies of NOVABLOC™ have shown up to 20 days of continuous pain reduction after knee replacement surgery with minimal opioid use. Clinical trial approval was obtained in October 2024, and the company has signed letters of intent with major rehabilitation centers nationwide.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- DeviceNon-invasive brain-computer interface (BCI)Neuromodulation therapy (for NOVABLOC™)
- Industry
- Physiological Monitoring
02
Partnerships
Letters of intent signed by major rehabilitation centers nationwide; no specific pharma or biotech partnerships disclosed yet.
Beyond the preview
Go deeper on Synaptrix Labs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Synaptrix Labs.